GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 238 | 172 | 371 | 424 | 486 |
| Receivables | 265 | 220 | 254 | 188 | 196 |
| Inventories | 354 | 322 | 314 | 301 | 304 |
| TOTAL | $1,024 | $931 | $1,050 | $1,051 | $1,154 |
| Non-Current Assets | |||||
| PPE Net | 37 | 49 | 59 | 62 | 59 |
| Intangibles | 877 | 907 | 812 | 818 | 820 |
| Other Non-Current Assets | 0 | 0 | 0 | 54 | 54 |
| TOTAL | $914 | $956 | $871 | $934 | $933 |
| Total Assets | $1,938 | $1,887 | $1,921 | $1,985 | $2,087 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 6 |
| Accounts payable and accrued liabilities | 436 | 575 | 392 | 321 | 305 |
| Accrued Expenses | 368 | 323 | 282 | 273 | 223 |
| Other current liabilities | 71 | 13 | 13 | 13 | 6 |
| TOTAL | $1,035 | $1,071 | $847 | $767 | $700 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,035 | $1,071 | $847 | $767 | $700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,306 | 25,994 | 10,106 | 10,006 | 10,030 |
| Common Shares | 26 | 25 | 10 | 10 | 10 |
| Retained earnings | -59,274 | -59,130 | -58,852 | -58,703 | -58,538 |
| Other shareholders' equity | -181 | 12 | 1,589 | 1,584 | 1,587 |
| TOTAL | $903 | $816 | $1,074 | $1,218 | $1,387 |
| Total Liabilities And Equity | $1,938 | $1,887 | $1,921 | $1,985 | $2,087 |